This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 May;169(5):1709.

doi: 10.1097/01.ju.0000057803.36190.0b.

Immunotherapy for bladder cancer. Is the black box becoming grayer?

H Barton Grossman

PMID: 12686814
DOI: 10.1097/01.ju.0000057803.36190.0b

Editorial

Immunotherapy for bladder cancer. Is the black box becoming grayer?

H Barton Grossman. J Urol. 2003 May.

. 2003 May;169(5):1709.

doi: 10.1097/01.ju.0000057803.36190.0b.

Author

H Barton Grossman

PMID: 12686814
DOI: 10.1097/01.ju.0000057803.36190.0b

No abstract available

PubMed Disclaimer

Comment on

The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY, Inci K, Erkan I, Ozen H. Bilen CY, et al. J Urol. 2003 May;169(5):1702-5. doi: 10.1097/01.ju.0000059681.67567.12. J Urol. 2003. PMID: 12686812
Defining bacillus Calmette-Guerin refractory superficial bladder tumors.
Herr HW, Dalbagni G. Herr HW, et al. J Urol. 2003 May;169(5):1706-8. doi: 10.1097/01.ju.0000062605.92268.c6. J Urol. 2003. PMID: 12686813

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information